Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
5hbs | RTL | Retinol-binding protein 1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
5hbs | RTL | Retinol-binding protein 1 | / | 1.000 | |
5h8t | RTL | Retinol-binding protein 1 | / | 0.644 | |
1crb | RTL | Retinol-binding protein 1 | / | 0.629 | |
1opb | RET | Retinol-binding protein 2 | / | 0.580 | |
1kqw | RTL | Cellular retinol-binding protein type II | / | 0.562 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.508 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.505 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.503 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.502 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.501 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.500 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.498 | |
3up0 | D7S | aceDAF-12 | / | 0.496 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.494 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.494 | |
2z3u | CRR | Cytochrome P450 | / | 0.491 | |
3a1l | 2CC | Cytochrome P450 | / | 0.491 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.491 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.490 | |
5iub | CLR | Adenosine receptor A2a | / | 0.490 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.489 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.488 | |
4qzu | RTL | Retinol-binding protein 2 | / | 0.488 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.488 | |
3rey | XAC | Adenosine receptor A2a | / | 0.487 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.482 | |
5gcn | COA | HAT A1 | / | 0.482 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.481 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.481 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.478 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.477 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.477 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.475 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.474 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.473 | |
3tm5 | SFG | Uncharacterized protein | / | 0.473 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.473 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.473 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.473 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.472 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.472 | |
3djl | FAD | Putative acyl-CoA dehydrogenase AidB | 1.3.99 | 0.472 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.472 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.471 | |
3cd2 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.471 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.471 | |
4ku5 | DCC | 3-oxoacyl-[ACP] synthase III | / | 0.471 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.471 | |
2dji | FAD | Pyruvate oxidase | / | 0.470 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.470 | |
3ibd | CPZ | Cytochrome P450 2B6 | 1.14.13 | 0.469 | |
3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.469 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.469 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.469 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.468 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.468 | |
3qak | UKA | Adenosine receptor A2a | / | 0.468 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.467 | |
2qx7 | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.467 | |
2wes | FAD | Tryptophan 5-halogenase | / | 0.467 | |
4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.467 | |
2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.466 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.466 | |
3up3 | XCA | aceDAF-12 | / | 0.466 | |
3uwl | FOZ | Thymidylate synthase | / | 0.466 | |
3jwc | EKB | Dihydrofolate reductase | / | 0.465 | |
3ule | C69 | Actin-related protein 3 | / | 0.465 | |
4h6r | FDA | Proline dehydrogenase | / | 0.465 | |
2hl2 | SSA | Threonine--tRNA ligase | 6.1.1.3 | 0.464 | |
4qin | SG8 | Smoothened homolog | / | 0.464 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.463 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.463 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.463 | |
4a2a | ATP | Cell division protein FtsA | / | 0.463 | |
4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.463 | |
4jlt | 8PR | Cytochrome P450 2B4 | 1.14.14.1 | 0.463 | |
1dfo | FFO | Serine hydroxymethyltransferase | 2.1.2.1 | 0.462 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.462 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.461 | |
1v5e | FAD | Pyruvate oxidase | / | 0.461 | |
3gkj | HC3 | Niemann-Pick C1 protein | / | 0.461 | |
3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.461 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.461 | |
4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.461 | |
1dd6 | MCI | Metallo-beta-lactamase type 2 | / | 0.460 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
4qe6 | JN3 | Bile acid receptor | / | 0.460 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
1ju6 | LYA | Thymidylate synthase | 2.1.1.45 | 0.459 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.459 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.459 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
2fto | CB3 | Thymidylate synthase | / | 0.458 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
3dei | RXB | Caspase-3 | 3.4.22.56 | 0.458 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.458 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.458 | |
4nie | NBH | Nuclear receptor ROR-gamma | / | 0.458 | |
1dgf | NDP | Catalase | 1.11.1.6 | 0.457 | |
1kzj | CB3 | Thymidylate synthase | / | 0.457 | |
2jla | TPP | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | / | 0.457 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2p9c | NAI | D-3-phosphoglycerate dehydrogenase | 1.1.1.95 | 0.457 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.456 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.456 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.456 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.456 | |
2r0c | FAD | Putative FAD-monooxygenase | / | 0.456 | |
2r6j | NDP | Eugenol synthase 1 | 1.1.1.318 | 0.456 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.456 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.456 | |
3nwl | NDP | Catalase | 1.11.1.6 | 0.456 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.456 | |
4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.456 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.456 | |
4l8u | 9AZ | Serum albumin | / | 0.456 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.456 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.455 | |
1f5f | DHT | Sex hormone-binding globulin | / | 0.455 | |
2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.455 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.455 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.455 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3p6p | A6B | Camphor 5-monooxygenase | 1.14.15.1 | 0.455 | |
3uku | C69 | Actin-related protein 3 | / | 0.455 | |
4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.455 | |
8cat | NDP | Catalase | 1.11.1.6 | 0.455 | |
2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.454 | |
2zl9 | VDA | Vitamin D3 receptor | / | 0.454 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.454 | |
4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.454 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
1cf3 | FAD | Glucose oxidase | 1.1.3.4 | 0.453 | |
1dgg | NDP | Catalase | 1.11.1.6 | 0.453 | |
1fml | RTL | Retinol dehydratase | / | 0.453 | |
1juv | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
2jfa | RAL | Estrogen receptor | / | 0.453 | |
2r0p | K2C | Putative FAD-monooxygenase | / | 0.453 | |
3g70 | A5T | Renin | 3.4.23.15 | 0.453 | |
3q44 | D50 | M1 family aminopeptidase | 3.4.11 | 0.453 | |
4a2b | AGS | Cell division protein FtsA | / | 0.453 | |
4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.453 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.453 | |
1bif | AGS | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 | 2.7.1.105 | 0.452 | |
1nhk | CMP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.452 | |
1sqv | UHD | Cytochrome b | / | 0.452 | |
1wsv | THH | Aminomethyltransferase, mitochondrial | / | 0.452 | |
1xu9 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
2bfm | TOP | Pteridine reductase 1 | 1.5.1.33 | 0.452 | |
2f2s | COA | Acetyl-CoA acetyltransferase, mitochondrial | 2.3.1.9 | 0.452 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
2yee | 2EC | Heat shock protein HSP 90-alpha | / | 0.452 | |
3d78 | NBB | Pheromone-binding protein ASP1 | / | 0.452 | |
3qv1 | NAD | Glyceraldehyde-3-phosphate dehydrogenase GAPA1, chloroplastic | 1.2.1.13 | 0.452 | |
3zbn | COA | 3-ketoacyl-CoA thiolase-like protein | / | 0.452 | |
3zc3 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.452 | |
4a87 | NAR | Major pollen allergen Bet v 1-A | / | 0.452 | |
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.452 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
1fm7 | DFV | Chalcone--flavonone isomerase 1 | 5.5.1.6 | 0.451 | |
1s19 | MC9 | Vitamin D3 receptor | / | 0.451 | |
1tl7 | ONM | Adenylate cyclase type 2 | / | 0.451 | |
1tl7 | ONM | Adenylate cyclase type 5 | / | 0.451 | |
2c59 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.451 | |
2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.451 | |
2p15 | EZT | Estrogen receptor | / | 0.451 | |
2vcw | ZZA | Hematopoietic prostaglandin D synthase | / | 0.451 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.451 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.451 | |
3td8 | D2R | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
3vt9 | YI4 | Vitamin D3 receptor | / | 0.451 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.451 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.451 | |
4bva | T3 | Ketimine reductase mu-crystallin | 1.5.1.25 | 0.451 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4g20 | 484 | Vitamin D3 receptor A | / | 0.451 | |
4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.451 | |
1ia1 | TQ3 | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
1juj | LYA | Thymidylate synthase | 2.1.1.45 | 0.450 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.450 | |
2ydw | WSH | Bromodomain-containing protein 2 | / | 0.450 | |
3ad9 | NAD | Subunit alpha of sarocosine oxidase | / | 0.450 | |
3hk1 | B64 | Fatty acid-binding protein, adipocyte | / | 0.450 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.450 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.450 | |
3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
3v49 | PK0 | Androgen receptor | / | 0.450 | |
3wix | LC3 | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.450 | |
4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.450 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.450 | |
4knz | CB3 | Thymidylate synthase | / | 0.450 | |
4lxj | LAN | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.450 | |
4v12 | POG | MaoC like domain protein | / | 0.450 | |
1nzd | UPG | DNA beta-glucosyltransferase | / | 0.449 | |
2v1a | FMN | NPH1-1 | / | 0.449 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
2xke | WI2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.449 | |
3bi5 | FAD | Polyamine oxidase FMS1 | / | 0.449 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.449 | |
3ey4 | 352 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.449 | |
3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.449 | |
3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
4c2j | COA | 3-ketoacyl-CoA thiolase, mitochondrial | 2.3.1.16 | 0.449 | |
4kwi | 1TJ | Reductase homolog | / | 0.449 | |
1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.448 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.448 | |
1txt | CAA | HMG-CoA synthase | / | 0.448 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
1xu7 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.448 | |
2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.448 | |
2zoq | 5ID | Mitogen-activated protein kinase 3 | 2.7.11.24 | 0.448 | |
3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
3gb4 | D3M | DdmC | / | 0.448 | |
3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.448 | |
3nxv | D2F | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.448 | |
4bkq | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.448 | |
4elb | 34S | Dihydrofolate reductase | / | 0.448 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.448 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
1re9 | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
1trg | CB3 | Thymidylate synthase | / | 0.447 | |
2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.447 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.447 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.447 | |
3dej | RXC | Caspase-3 | 3.4.22.56 | 0.447 | |
3h6k | 33T | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.447 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.447 | |
3ngu | ADP | Nucleoside diphosphate kinase | / | 0.447 | |
3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.447 | |
3sf6 | FDA | Glutaryl-CoA dehydrogenase | / | 0.447 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.447 | |
4jqh | 1MF | Alr2278 protein | / | 0.447 | |
5doz | NDP | JamJ | / | 0.447 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.446 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.446 | |
1jtu | LYB | Thymidylate synthase | / | 0.446 | |
1z6l | FAD | Polyamine oxidase FMS1 | / | 0.446 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.446 | |
2c54 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.446 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.446 | |
2kce | D16 | Thymidylate synthase | / | 0.446 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.446 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
2w3v | TOP | Dihydrofolate reductase | / | 0.446 | |
2w4q | CBW | Prostaglandin reductase 2 | 1.3.1.48 | 0.446 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
2y30 | SM8 | Putative repressor SimReg2 | / | 0.446 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.446 | |
3vtb | TKA | Vitamin D3 receptor | / | 0.446 | |
4elf | 35I | Dihydrofolate reductase | / | 0.446 | |
4fhh | 0U3 | Vitamin D3 receptor A | / | 0.446 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.446 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.446 | |
4tzk | 641 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
1bi9 | NAD | Retinal dehydrogenase 2 | / | 0.445 | |
1ddt | APU | Diphtheria toxin | / | 0.445 | |
1ek2 | CDU | Bifunctional epoxide hydrolase 2 | / | 0.445 | |
1nbh | SAM | Glycine N-methyltransferase | 2.1.1.20 | 0.445 | |
1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
2aq7 | TL5 | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.445 | |
2cah | NDP | Catalase | 1.11.1.6 | 0.445 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.445 | |
3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
3qlw | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.445 | |
4elb | 34R | Dihydrofolate reductase | / | 0.445 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
4hfr | 14M | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
4iq7 | 1G9 | Mycocyclosin synthase | 1.14.21.9 | 0.445 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.445 | |
1cbq | RE9 | Cellular retinoic acid-binding protein 2 | / | 0.444 | |
2a4z | BYM | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.444 | |
2bns | MST | Reaction center protein L chain | / | 0.444 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
2bw7 | ECS | Adenylate cyclase | / | 0.444 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.444 | |
2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.444 | |
3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
3ft8 | MOJ | Heat shock protein HSP 90-alpha | / | 0.444 | |
3nbv | ANP | Ketohexokinase | / | 0.444 | |
3sfi | 3SF | HTH-type transcriptional regulator EthR | / | 0.444 | |
4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.444 | |
4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.444 | |
4dw6 | 0MN | HTH-type transcriptional regulator EthR | / | 0.444 | |
4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
5hwq | CAA | Hydroxymethylglutaryl-CoA synthase | / | 0.444 | |
7cat | NDP | Catalase | 1.11.1.6 | 0.444 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.444 | |
1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.443 | |
1kt3 | RTL | Retinol-binding protein 4 | / | 0.443 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.443 | |
2nsd | 4PI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.443 | |
2ynf | WHU | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
3c35 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.443 | |
3cse | N22 | Uncharacterized protein | / | 0.443 | |
3dxm | N24 | Actin-related protein 3 | / | 0.443 | |
3gie | ACP | Sensor histidine kinase DesK | 2.7.13.3 | 0.443 | |
3lla | ACP | Myosin heavy chain kinase A | 2.7.11.7 | 0.443 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.443 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
3stu | DK3 | Methylketone synthase I | / | 0.443 | |
3stx | BKA | Methylketone synthase I | / | 0.443 | |
4jld | ADP | Adenylate kinase | / | 0.443 | |
4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
4ktf | 1TM | Cytochrome P450 | / | 0.443 | |
1dgb | NDP | Catalase | 1.11.1.6 | 0.442 | |
1e1k | NAP | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.442 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1jla | TNK | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
1ot7 | CHC | Bile acid receptor | / | 0.442 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
2pbw | DOQ | Glutamate receptor ionotropic, kainate 1 | / | 0.442 | |
2pg0 | FAD | Acyl-CoA dehydrogenase | / | 0.442 | |
2w98 | P1Z | Prostaglandin reductase 2 | 1.3.1.48 | 0.442 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
2xls | FAD | Putative flavin-containing monooxygenase | / | 0.442 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.442 | |
3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3i6q | NDP | Putative leucoanthocyanidin reductase 1 | / | 0.442 | |
3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.442 | |
3vtc | TK3 | Vitamin D3 receptor | / | 0.442 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.442 | |
4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.442 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.442 | |
1d6w | 00R | Prothrombin | 3.4.21.5 | 0.441 | |
1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.441 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.441 | |
1osv | CHC | Bile acid receptor | / | 0.441 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.441 | |
1qkn | RAL | Estrogen receptor beta | / | 0.441 | |
1rjk | VDZ | Vitamin D3 receptor | / | 0.441 | |
1txz | APR | Probable ADP-ribose 1''-phosphate phosphatase YML087W | 3.1.3.84 | 0.441 | |
1zdw | FLV | Prenyltransferase | / | 0.441 | |
2gtm | LID | Mitogen-activated protein kinase 14 | / | 0.441 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.441 | |
2vcz | VC3 | Hematopoietic prostaglandin D synthase | / | 0.441 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.441 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.441 | |
3i0r | RT3 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.441 | |
3v94 | WYQ | Phosphodiesterase | / | 0.441 | |
3vi5 | M4M | Hematopoietic prostaglandin D synthase | / | 0.441 | |
3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.441 | |
3zk6 | H1I | Bcl-2-like protein 1 | / | 0.441 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
4cs0 | ACO | PanD regulatory factor | / | 0.441 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4fwe | FAD | Lysine-specific histone demethylase 1B | 1 | 0.441 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.441 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4itf | TFY | Vitamin D3 receptor | / | 0.441 | |
4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.441 | |
4o7u | THF | Thymidylate synthase | / | 0.441 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.441 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.441 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.440 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.440 | |
1qax | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.440 | |
2b03 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.440 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.440 | |
2jj2 | ANP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.440 | |
2nv6 | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3bx5 | 304 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
3pqb | VGP | Putative oxidoreductase | / | 0.440 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.440 | |
3w0y | DS4 | Vitamin D3 receptor | / | 0.440 | |
3zku | HCV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
4b7x | NAP | Probable oxidoreductase | / | 0.440 | |
4e37 | NDP | Catalase | 1.11.1.6 | 0.440 | |
4e4q | RRH | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
4fgh | 0U6 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 |